The goodness‐of‐fit of the used model increased when f‐Hb concentrations of both rounds (as opposed to only the last measured f‐Hb concentration) were included to estimate the OR of interval CRC after the second round. This evidence concerns the gene GSTM1 and colorectal carcinoma.